Trelagliptin(SYR-472) is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).

June 21, 2017

prudect name : Trelagliptin(SYR-472) is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
Trelagliptin succinate;SYR-472

Synonyms: CAS NO: 1029877-94-8Molecular Formula: C₁₈H₂₀FN₅O₂.C₄H₆O₄Molecular Weight: 475.47Purity: 98% minSolubility: In DMSOStorage: -20 oC